Prevention of Perioperative Surgical Site Infection


Introduction

Surgical site infections (SSIs) are now the most common cause of hospital-acquired infections (HAIs), accounting for approximately 20% of all HAIs in hospitalized patients. Approximately 160,000–300,000 SSIs occur each year in the United States and 2%–5% occur in patients undergoing inpatient surgery. SSIs are associated with worse outcomes, including a 2- to 11-fold increase in the risk of mortality. Although most patients recover from an SSI without long-term adverse sequelae, 77% of mortality in patients with an SSI can be directly attributed to the infection itself. Attributable costs of SSI vary depending on the type of operative procedure and the type of infecting pathogen, but SSIs are believed to account for $3.5 to $10 billion annually in health-care expenditures. On average, SSIs extend hospital length of stay by 7–11 days and increase the cost of hospitalization by more than $20,000 per admission.

All surgical wounds are contaminated by bacteria, but only a minority result in clinical infections. In most patients, an infection does not develop because innate host defenses are quite efficient in eliminating contaminants at the surgical site. Development of SSI after surgery depends on complex interactions between (1) patient-related factors such as age, obesity, diabetes, host immunity, and nutritional status (2) procedure-related factors such as placement of a foreign body, duration of operation, skin antisepsis, and the magnitude of tissue trauma; (3) microbial factors that mediate tissue adherence and invasion or that enable the bacterium to survive the host immune response and to colonize or infect the host concurrently; and (4) perioperative antimicrobial prophylaxis.

Surgical Site Infection

Classification of SSI

Classification of wounds can be based on the degree of bacterial load or contamination that they contain. Since the landmark 1964 National Academy of Sciences’ National Research Council study on the use of ultraviolet lights in the operating room (OR), wounds have been classified by the level of risk of contamination. The four categories are clean, clean/contaminated, contaminated, and dirty/infected. This classification of the degree of contamination in the surgical site during surgery has become the traditional system for predicting infection risk in surgical wounds.

SSIs are classified into three groups: (1) superficial incisional, (2) deep incisional, and (3) organ/space. A superficial incisional SSI involves only the skin or subcutaneous tissue, a deep incisional SSI involves the fascia or muscular layers, and an organ/space SSI involves any part of the body opened or manipulated during the operative procedure, excluding the previously mentioned layers. The criteria used for defining an SSI are listed in Box 28.1 . The identification of SSI involves interpretation of clinical and laboratory data. The Centers for Disease Control and Prevention (CDC) has derived standardized surveillance definitions and these criteria must be applied consistently when classifying an SSI.

Box 28.1
From National Healthcare Safety Network, Surgical Site Infection (SSI) Event. Centers for Disease Control and Prevention; Atlanta: 2013, and available at www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf .
Criteria for defining a surgical site infection.

Superficial incisional SSI

  • Occurs within 30 days after the operation, AND

  • Involves only the skin or subcutaneous tissue of the incision, AND

  • At least one of the following:

    • Purulent drainage from the superficial incision

    • Organisms isolated from an aseptically obtained culture or nonculture-based microbiologic testing method of fluid or tissue from the superficial incision or subcutaneous tissue

    • Superficial incision that is deliberately opened by a surgeon, attending physician, or other designee when the patient has at least one of the following signs or symptoms: pain or tenderness, localized swelling, erythema, or heat unless the incision is culture negative

    • Diagnosis of superficial incisional SSI by the surgeon or attending physician or other designee

Deep incisional SSI

  • Occurs within 30 or 90 days after the operation according to NHSN’s table of operative procedures, AND

  • Involves deep soft tissues (e.g., fascial and muscle layers) of the incision, AND

  • At least one of the following:

    • Purulent drainage from the deep incision

    • A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms: fever, localized pain or tenderness unless the site is culture negative

    • An abscess or other evidence of infection involving the deep incision that is detected on gross anatomic or histopathologic examination, or imaging test

Organ/space SSI

  • Occurs within 30 or 90 days after the operation according to NHSN’s table of operative procedures, AND

  • Involves any part of the body deeper than the fascial/muscle layers (e.g., organs or spaces) that is opened or manipulated during the operative procedure, AND

  • At least one of the following:

    • Purulent drainage from a drain that is placed into the organ/space

    • Organisms isolated from a culture or non culture based microbiologic testing method of fluid or tissue in the organ/space

    • Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/space

    • An abscess or other evidence of infection involving the organ/space that is detected on gross anatomical or histopathologic examination, or imaging test

  • Meets at least one criterion for a specific organ/space infection site specified by NHSN

SSI , surgical site infection.

Microbiology

The risk of infection increases once the site has been contaminated with greater than 10 5 organisms per gram of tissue. The bacterial burden necessary to cause infection is significantly reduced when foreign material is in place (i.e., only 100 staphylococci per gram of tissue when introduced on silk sutures). Risk is also proportional to the toxins produced by the specific pathogen because these agents can facilitate host invasion, damage tissues, and interfere with host defenses.

The pathogens responsible for SSIs have not significantly changed over time. Table 28.1 lists the distribution of pathogens associated with SSIs. Staphylococcus aureus, Escherichia coli, coagulase-negative staphylococci, and Enterococcus faecalis represent nearly 50% of the pathogens associated with SSIs. S. aureus is the most common SSI pathogen for most types of surgery, but E. coli is more prevalent in abdominal surgery and Enterococcus species are most prevalent in transplant surgery.

Table 28.1
Distribution of pathogens associated with surgical site infections frequently reported to the National Health-care Safety Network, 2011–2014.
Adapted from Weiner, L. M., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 2016;37(11): 1288-1301.
Pathogen No. of pathogens % of pathogens
Staphylococcus aureus 30,902 20.7
Escherichia coli 20,429 13.7
Coagulase-negative staphylococci 11,799 7.9
Enterococcus faecalis 11,156 7.5
Pseudomonas aeruginosa 8458 5.7
Klebsiella (pneumoniae/oxytoca) 7067 4.7
Bacteroides species 7041 4.7
Enterobacter species 6615 4.4
Other Enterococcus species 6410 4.3
Proteus species 4196 2.8
Enterococcus faecium 4140 2.8
Candida albicans 3351 2.2
Viridans streptococci 2639 1.8
Group B streptococci 1879 1.3
Serratia species 1857 1.2
Other pathogens 21,070 14.1
Total 149,009 100

Sources of Pathogens

The primary source of SSI pathogens is the endogenous flora of the patient’s skin, mucous membranes, or hollow viscera. When the mucous membrane or skin is incised, the exposed tissues are at risk of contamination with endogenous flora. These organisms are usually aerobic gram-positive cocci (e.g., staphylococci). When an organ system is entered, endogenous flora specific to it may be the source of the pathogen (e.g., enteric flora such as E. coli or other gram-negative rods when bowel surgery is performed).

Surgical pathogens can also be derived from exogenous sources. Examples include surgical personnel (especially members of the surgical team), the OR environment (including air), and materials on the sterile field (such as instruments, equipment, containers) during an operation. Exogenous flora are primarily aerobes, especially gram-positive organisms (e.g., staphylococci and streptococci). Although S. aureus is usually from an endogenous source, evidence suggests exogenous pathways as well. Fungal SSIs are infrequent but can be endogenously or exogenously derived. Nevertheless, there are over two dozen reports of Candida infections in prosthetic joints, and a growing number of studies report Candida infections after cardiac surgery. Although these infections are infrequent, they are associated with serious problems, including a greater than 50% mortality.

Risk Factors

A risk factor is a characteristic statistically associated with, although not necessarily causally related to, an increased risk for a particular outcome. Risk factors for developing an SSI after surgery can be broadly separated into preoperative, intraoperative, and postoperative settings and relate to patient, procedure, or facility factors ( Table 28.2 ). Nonmodifiable patient factors include increasing age, recent radiotherapy, and preexisting or history of skin or soft tissue infection. Potentially modifiable patient risk factors include glycemic control, alcohol, smoking status, malnutrition, obesity, and immunosuppression. Procedure-related factors include emergency surgery, surgical complexity, and wound classification. Facility risk factors include inadequate ventilation, increasing OR traffic, and inappropriate sterilization of equipment. In this section, preoperative, intraoperative, and postoperative preventative strategies for SSI will be examined in further detail.

Table 28.2
Risk factors for surgical site infection.
Adapted from Ban, KA et al. Executive summary of the American College of Surgeons/Surgical Infection Society Surgical Site Infection Guidelines 2016 Update. Surg Infect (Larchmt) 2017;18(4):379-382.
Preoperative setting
Patient-related factors
  • Nonmodifiable

  • Increased age

  • Recent radiotherapy

  • Preexisting or history of skin or soft tissue infection

  • Modifiable

  • Diabetes

  • Obesity

  • Alcoholism

  • Current smoker

  • Hyperbilirubinemia

  • Malnutrition

  • Immunosuppression

Intraoperative setting
Patient-related factors
  • Inadequate skin preparation

  • Hair removal method

  • Poor glycemic control

Procedure-related factors
  • Procedure type

  • Emergency

  • Higher procedure complexity

  • Higher wound classification

  • Longer procedure duration

  • Blood transfusion

  • Breach in asepsis technique

  • Inappropriate antibiotic choice, timing, weight-based dosing, and redosing

  • Inadequate gowning and gloving

  • Inappropriate surgical scrub

Facility-related factors
  • Inadequate ventilation

  • Increased operating room traffic

  • Contaminated environmental surfaces

  • Nonsterile equipment

Postoperative setting
  • Inappropriate postoperative antibiotics

  • Poor glycemic control

Prevention of Surgical Site Infection

Preoperative Setting

Patient-Related Factors

Diabetes Status and Control

Diabetes mellitus is a well-known risk factor for adverse medical events. Historically, increased risk for infection is thought to result from a combination of the long-term effects of hyperglycemia (e.g., macrovascular and microvascular disease) and the poor wound healing associated with neutrophil, complement, and antibody dysfunction. However, more recent data linking long-term blood glucose control and SSI risk have been mixed. A retrospective Veterans Affairs National Surgical Quality Improvement Program (VA NSQIP) study reported that an elevated Hgb A1c (marker of long-term glucose control) is associated with increased risk of postoperative infections and that Hgb A1c less than 7% was significantly associated with increased infectious complications. However, subsequent studies using multivariable analysis suggest that perioperative hyperglycemia, as opposed to elevated Hgb A1c, is associated with decreased SSI risk. Interestingly, several studies show that perioperative hyperglycemia increases the risk of SSI in both diabetic and nondiabetic patients. These studies suggest that short-term glucose control perioperatively may be more important than long-term Hgb A1c control in preventing SSIs.

Smoking Cessation

Smoking is another well-known risk factor for postoperative infectious complications. The etiology is complex but probably mediated through three principal mechanisms: (1) tissue perfusion and oxygenation, (2) impairment of inflammatory cell functions and oxidative bactericidal mechanisms, and (3) attenuation of proliferative responses including reduced fibroblast migration and collagen synthesis and deposition. The effect of smoking is especially pronounced in cases in which foreign materials or prosthetics are implanted. The negative effect of smoking on SSI risk has been demonstrated across all surgical specialties, with current smokers carrying the highest risk followed by former smokers. The fact that former smokers have a higher risk of SSI compared with those who have never smoked demonstrates that the detrimental effect of smoking is prolonged or possibly even irreversible. Studies have shown that inflammatory cell response and bactericidal mechanisms improve after 4 weeks of abstinence from smoking, but impairment of proliferative responses may persist. Nevertheless, smoking cessation has been shown to be effective in reducing SSI risk and patients should be counseled to refrain from smoking for a minimum of 4 to 6 weeks prior to elective surgery. The effect of nicotine replacement therapy on wound microenvironment and healing is still poorly understood, but there is no evidence to suggest detrimental clinical effects on postoperative outcomes. Current opinion supports the use of nicotine replacement therapy as an aid to smoking cessation before surgery.

Malnutrition

Preoperative malnutrition is a known risk factor for poor outcomes following surgery. Nutritional factors play critical roles in regulating metabolic pathways and immune system functions. A multicenter study found that preoperative hypoalbuminemia was an independent risk factor for SSI development after abdominal surgery. This effect has also been shown in many other types of surgeries. However, there is no consistent evidence for malnutrition screening and nutritional optimization prior to surgery. One Cochrane systematic review evaluated nutritional supplementation in elderly patients recovering from hip fracture that concluded that there is overall low-quality evidence to support nutritional interventions before or soon after surgery to prevent infectious complications.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here